景嘉微(300474.SZ)擬斥500萬元設立太原全資子公司
格隆匯 8 月 4日丨景嘉微(300474.SZ)公佈,公司於2020年8月4日,召開第三屆董事會第二十三次會議,審議通過了《關於擬設立太原全資子公司的議案》。為了滿足公司未來發展需要,公司擬以自有資金500萬元人民幣在太原市設立全資子公司。經營範圍:集成電路設計;集成電路製造;計算機技術開發、技術服務、計算機零部件製造;計算機外圍設備製造;計算機信息安全設備製造;電子產品零售;電子產品研發、電子產品設計服務;計算機、計算機軟件、計算機輔助設備的銷售。
此次投資設立全資子公司是基於公司戰略發展需要,充分發揮區域優勢,進一步擴大公司產能,有利於優化公司資源配置,為公司的持續長遠發展提供有力的保障。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.